Advertisements


The Campus Roundup: Feb. 25, 2021

A weekly summary of Business Journals coverage of personnel, fundraising and program news at colleges and universities throughout the country......»»

Category: topSource: bizjournalsFeb 25th, 2021

How to watch college football without cable - the 2021 season continues with new matchups on September 25

The 2021 NCAA college football season is in full swing. We rounded up the best streaming services for catching all the action without cable. When you buy through our links, Insider may earn an affiliate commission. Learn more. Notre Dame's college football team faces off against Wisconsin on September 25. Michael Hickey/Getty Images The 2021 NCAA college football season began on August 28 and runs through December. Games are broadcast on local stations, national networks, and college sports channels. You can watch select college football matches without cable via live TV streaming services like Sling TV. Table of Contents: Masthead StickyThe 2021 NCAA college football season kicked off in late August and will continue through December. Playoffs occur after the regular season ends, and the championship game is currently scheduled for January 10.As we enter Week Four, several exciting matchups are set for September 25. Most notably, Notre Dame faces Wisconsin at 12 p.m. ET on Fox, and Texas A&M takes on Arkansas at 3:30 p.m. ET on CBS.College football games are primarily broadcast in one of three ways: on local channels, on cable networks, or on college sports networks. Select games will also be available to stream via ESPN+.Below, we broke down some of the best ways to watch college football without cable, so you can stay up to date with your favorite teams.How to watch college football without cableYou can watch local college football games for free by using an HDTV antenna. In order to watch games that are broadcast on pay-TV or college sports networks, you need a subscription to a streaming service like Sling TV, Hulu with Live TV, or YouTube TV.The core local channels with access to college football games are ABC, CBS, Fox, and NBC. National stations like ESPN, Fox Sports 1 (FS1), and CBSSN broadcast select college football games. Additional games are available through college sports networks such as the ACC Network, Big Ten Network, and SEC Network.The number of channels that broadcast college football games can be a little overwhelming, so we put together a list featuring some of the best ways to stream games without a cable subscription.Here's a roundup of services you can use to watch college football without cable: HDTV Antenna StackSocial TV Antenna (small)If your main concern is rooting for your local college football team, an HDTV antenna is one of the most affordable options. A one-time purchase of an inexpensive antenna unlocks access to over-the-air (OTA) signals near you, and allows you to stream any available local affiliates of ABC, CBS, Fox, or NBC. An HDTV antenna is a great, budget-friendly option for streaming local games and does not require any monthly subscription. The major downside is that it doesn't give you access to games broadcast on cable channels like ESPN or out-of-market games.What college football channels you can get: ABCCBSFoxNBC Sling TV Antonio Villas-Boas/Business Insider TV (small)Sling TV is one of the most affordable live TV streaming services with access to college football games. Sling's two core plans, Orange and Blue, start at just $35 a month. If you want to watch games broadcast on ESPN and ESPN2, then Sling Orange is a great choice. Looking for the college football games airing on FS1 and NBC? Then Sling Blue is the best plan for you. Sling also offers a bundle option that combines all the channels from the Orange and Blue plan for just $50 a month. New customers to Sling TV currently receive $25 off their first month of service to the Orange or Blue plans, and $30 off their first month of the combined plan.For an extra $11 a month, you can add access to college sports channels like the Big Ten Network and the SEC Network with the Sports Plus add-on package.What college football channels you can get: Sling Orange:ESPNESPN 2StadiumACC Network*ACC Network Extra*ESPNU*SEC Network*SEC Network+*Pac-12 Network*Sling Blue:NBCFoxFS1StadiumPac-12 Network*Big Ten Network**Available as an add-on channel Hulu with Live TV Ahmad Danial Zulhilmi/Shutterstock + Live TV (small)If you want to get access to a vast library of movies, TV shows, and originals with your live TV subscription service, Hulu + Live TV could be a great fit for your needs. A subscription to Hulu + Live TV starts at $65 a month. With Hulu + Live TV, you get access to available local affiliate channels, like ABC, CBS, NBC, and Fox. You also unlock many important broadcast channels for watching nationally televised college football games such as ESPN, ESPN2, FS1, and more. Unlike Sling TV, Hulu + Live TV includes access to the SEC Network and ESPNU in their basic subscription plan.What college football channels you can get: ABCCBSNBCFoxCBSSNESPNESPN2ESPNUFS1ACC NetworkBig Ten NetworkSEC Network YouTube TV YouTube TV TV (small)As a live TV streaming service, YouTube TV includes many of the same features as Hulu + Live TV without the vast catalog of on-demand entertainment. A subscription to YouTube TV starts at $65 a month.The channels available with a YouTube TV subscription closely mirror what is offered through Hulu + Live TV. You get access to local affiliates and all the important cable channels like ESPN, FS1, and CBSSN. Similar to Hulu + Live TV, college sports channels, such as the SEC Network, Big Ten Network, and ESPNU are included as part of the base plan for YouTube TV. The one main difference between the two services is that you can purchase a Sports Plus add-on for YouTube TV that costs $11 a month and includes the Stadium College Sports channel.What college football channels you can get: ABCCBSNBCFoxCBSSNESPNESPN2ESPNUFS1ACC NetworkBig Ten NetworkSEC Network FuboTV Reuters/Carlo Allegri TV (Starter Plan) (small)FuboTV is another quality live TV streaming service with access to college football games. Starting at $65 a month, the streaming service has the same basic rate as Hulu + Live TV and YouTube TV.You can watch games that air on local affiliate channels and core broadcast channels with FuboTV. The streaming service offers certain college sports channels in its base plan, like the Big Ten Network and CBS Sports Network, but the options are more limited than what is offered through Hulu + Live TV or YouTube TV.Certain channels with college football games, such as the ACC Network, SEC Network, and ESPNU, are available in add-on packages for FuboTV.What college football channels you can get: ABCCBSNBCFoxCBSSNESPNESPN2ESPNU*FS1ACC Network*Big Ten NetworkSEC Network*Pac-12 Network*Stadium**Available as an add-on channel Paramount Plus Paramount + Essential Monthly Plan (ad-supported) (small)If your main concern is watching the SEC football games airing on CBS, then Paramount Plus is a great streaming service for you. Plans for Paramount Plus start at $5 a month and include access to the college football games broadcast on CBS.You also get thousands of hours of on-demand movies, TV shows, and original content with a subscription to Paramount Plus.  ESPN+ ESPN+ Monthly Subscription Service (small)ESPN+ doesn't give you access to the ESPN channel, but for $7 a month, you can live stream select college football games from the MVFC, Ohio Valley, Southern Conference, and more. This is a great supplemental streaming service if you want to watch more niche college football games that are often not nationally broadcast. Read the original article on Business Insider.....»»

Category: worldSource: nytSep 24th, 2021

How to watch the NFL without cable - the 2021 season enters Week 3 with a Thursday night game on NFL Network

The 2021 NFL season kicked off September 9; you can watch select games live on streaming services like Sling and Fubo TV all season long. When you buy through our links, Insider may earn an affiliate commission. Learn more. The 2021 NFL season began on September 9. Mark J. Terrill/AP Photo; Mark LoMoglio/AP Photo; Alyssa Powell/Business Insider The 2021 NFL season enters its third week with major matchups, like Bucs vs. Rams and Packers vs. 49ers. Games are spread across several channels, including NFL Network, ESPN, NBC, Fox, and CBS. HD antennas and streaming services offer select NFL games without the need for a cable subscription. Table of Contents: Masthead StickyThe 2021 NFL season heads into its third week with a Thursday night matchup between the Carolina Panthers and Houston Texans. The game starts at 8:20 p.m. ET on the NFL Network.Throughout the season, NFL games are spread across five primary channels: ESPN, NBC, Fox, CBS, and the NFL Network. Meanwhile, the next Super Bowl will be broadcast on NBC.To help ensure you get access to every game you want to watch, we' broke down the ins and outs of streaming the NFL season without a cable subscription.NFL Week 3 scheduleWeek three of the NFL regular season includes a Sunday Night Football matchup between the Green Bay Packers and San Francisco 49ers on NBC and Peacock. This week's Monday Night Football game will feature the Philadelphia Eagles and Dallas Cowboys on ESPN.Primetime games are shown nationally, but local broadcasts for afternoon games are determined by your area. Byes will not start until after week four.GameDate and timeChannelCarolina Panthers at Houston TexansSeptember 23, 8:20 p.m. ETNFL NetworkIndianapolis Colts at Tennessee TitansSeptember 26, 1 p.m. ETCBSAtlanta Falcons at New York GiantsSeptember 26, 1 p.m. ETFOXSan Diego Chargers at Kansas City ChiefsSeptember 26, 1 p.m. ETCBSCincinnati Bengals at Pittsburgh SteelersSeptember 26, 1 p.m. ETCBSChicago Bears at Cleveland BrownsSeptember 26, 1 p.m. ETFOXBaltimore Ravens at Detroit LionsSeptember 26, 1 p.m. ETCBSNew Orleans Saints at New England PatriotsSeptember 26, 1 p.m. ETFOXArizona Cardinals at Jacksonville JaguarsSeptember 26, 1 p.m. ETFOXWashington Football Team at Buffalo BillsSeptember 26, 1 p.m. ETFOXNew York Jets at Denver BroncosSeptember 26, 4:05 p.m. ETCBSMiami Dolphins at Las Vegas RaidersSeptember 26, 4:05 p.m. ETCBSSeattle Seahawks at Minnesota VikingsSeptember 26, 4:25 p.m. ETFOXTampa Bay Buccaneers at Los Angeles RamsSeptember 26, 4:25 p.m. ETFOXGreen Bay Packers at San Francisco 49ersSeptember 26, 8:20 p.m. ETNBC, Peacock PremiumPhiladelphia Eagles at Dallas CowboysSeptember 27, 8:15 p.m. ETESPN, ESPN2How to watch NFL games without cableYou can access select NFL games without a cable subscription via streaming services like Hulu + Live TV, Sling TV, FuboTV, YouTube TV, Paramount Plus, Amazon Prime Video, Peacock Premium, and NFL Sunday Ticket. You can also watch local NFL games with an HDTV antenna.The 2021 NFL regular season began on September 9. During the regular season, Sunday afternoon games with an NFC home team will typically air on Fox, and Sunday afternoon games with an AFC home team will typically air on CBS.Meanwhile, Sunday Night Football airs on NBC, and Thursday Night Football will broadcast on NFL Network all season long. Select Thursday Night Football games will also be shown on Fox and streamed via Amazon Prime and Twitch. Finally, Monday Night Football is on ESPN. Additionally, you can stream all your local in-market games on your mobile device for free using the Yahoo Sports app or the NFL app.Here's a full roundup of all the services you can use to stream NFL games without cable. HDTV Antenna Amazon You can purchase an antenna, like this 1 By One model, to add to your TV for about $24, giving you access to local channels within a certain distance. What you get:Hooking up an HD antenna to your TV gives you access to local over-the-air (OTA) signals in your location. This means that you will be able to access the local affiliates of major broadcast networks, like Fox, CBS, and NBC.This lets you watch all the regional games broadcast from wherever you're located. You also get the Sunday Night Football matchup that airs on NBC. Because it's only a one-time payment, this is a great option if you're solely interested in watching the team in your area. However, you will not get access to any out-of-market games or games that air on ESPN or the NFL Network. Sling TV Alyssa Powell/Business Insider If you're looking for a live TV streaming service to watch football, Sling TV is a great budget option that gives you most of the channels you need at a cheaper price than Hulu or FuboTV.There are three different plans, depending on what channels you prioritize. Sling Orange and Sling Blue each cost $35 a month, while the combined Sling Orange + Blue plan costs $50 per month. Additionally, you can purchase the Sports Extra package to add NFL RedZone to your plan for $11 per month.What you get:Sling Orange has ESPN, while Sling Blue has Fox and NBC in select markets as well as the NFL network. CBS is not currently offered by Sling. While there is a Sports Extra package, it does not include any channels that air live NFL games. Your best bet to get access to the most NFL games via Sling is to sign up for the Sling Orange + Blue plan and cash in on Sling's current promotional offer of a free antenna for local channels. The free antenna requires that you prepay for two months of the Sling service. Plus, if you want RedZone you can add the Sports Extra package to the Orange + Blue Plan for a total of $61 a month.If you don't want it all, you can just sign up for Sling Blue to gain access to Sunday afternoon games on Fox and Sunday Night Football games on NBC, or just Sling Orange to gain access to Monday Night games on ESPN, in addition to the local offerings included with the antenna. As with all streaming services, game availability is subject to blackouts.With Sling's channel listings, add-ons, and the fact that they provide a free antenna, you can gain access to all local channels, the NFL Network, ESPN, and NFL RedZone, making it one of the most cost-effective ways to watch the NFL without cable. TV (small) Hulu with Live TV Business Insider In addition to all of its other offerings, Hulu + Live TV has nearly everything you need to stream NFL games for $65 per month. However, like Sling TV, there's no option to add the NFL Network or NFL RedZone as a channel, which could be a deal-breaker if you're hoping to watch and monitor action across the league.What you get: Like an HD antenna, Hulu + Live TV gets you access to all the local affiliates of the major broadcasts, meaning Fox, CBS, and NBC. These will show the games that are within your regional broadcast map with the exception of any blackouts. In addition, you also get ESPN, which gives you access to all Monday Night Football games, and some of the best NFL coverage and analysis on TV. While you don't get access to watch out-of-network games from across the country like you do with NFL RedZone or NFL Sunday Ticket, this is a comprehensive way to tune into most locally and nationally televised games. Hulu does not offer a way to watch the first three regular Thursday Night Football games, however, since those will be aired on NFL Network.  FuboTV FuboTV At $65 a month for the Starter Plan, FuboTV is one of the most comprehensive yet expensive live streaming options for NFL football. You can also spend an extra $11 per month to add the Sports Plus with NFL RedZone package.What you get:In terms of NFL games, the Starter Plan includes access to local CBS, NBC, and Fox stations (regional availability and blackout restrictions apply). FuboTV's Starter Plan also grants you access to ESPN to watch Monday Night Football, and NFL Network to stream Thursday Night Football all season long.  YouTube TV YouTube With a base price of $65 a month, YouTube TV is another service that offers access to most NFL games. Additionally, the service announced an agreement with the NFL to offer NFL Redzone as an add-on included in their Sports Plus package for an additional $11 a month. What you get:Like other services at this price range, YouTube TV offers access to all the local channels you need to watch NFL games, including CBS, Fox, and NBC. YouTube TV also offers ESPN and NFL Network in their base package, so you'll be able to watch all Monday Night Football and Thursday Night Football games. And with the news of the new Sports Plus package, you can also watch NFL Redzone for an additional $11 per month. NFL Sunday Ticket REUTERS/Carlo Allegri NFL Sunday Ticket used to only be available with a cable subscription, but NFL fans in non-DirecTV markets anywhere in the country can now gain access to every Sunday afternoon game.There are two separate plans available: The NFL Sunday Ticket To Go plan costs $73.49 per month for four months, which is $293.96 total. There is also the NFL Sunday Ticket Max plan for $99 per month for four months, adding up to $396 total.What you get:Both plans give you access to all out-of-market Sunday afternoon games. This means that you do not get access to Thursday, Sunday, or Monday night games. You also won't be able to stream locally televised games with only an NFL Sunday Ticket subscription. However, this is the only way for people hoping to watch full live games of their favorite teams out of market. A fun feature included in both plans is that you can watch four games at once on your screen.In addition to the normal features, NFL Sunday Ticket Max adds in NFL RedZone and the DirecTV Fantasy Zone, which is a new channel solely dedicated watching games through the lens of fantasy football.  Paramount Plus CBS If you're just interested in watching locally televised AFC home games, then a Paramount Plus subscription could be all you need. The service lets you stream live CBS television, as well as a growing library of on-demand shows and exclusive titles. Paramount Plus is available for $5 a month with commercials or $10 a month with ad-free streaming. With that said, all live broadcasts, including NFL games, still feature commercials with the ad-free plan.What you get:Paramount Plus offers live streaming for every NFL game that airs on the regular CBS channel in your local market. However, since Paramount Plus only offers CBS content you won't be able to watch any games that air on other networks or any out of market matches. You can see a full schedule of NFL games set to air on CBS here.Essential Monthly Plan (ad-supported) (small)Premium Monthly Plan (ad-free) (small) Peacock Premium Peacock Peacock won't be streaming any exclusive games during the 2021 season, but Premium subscribers can stream all the NFL games being broadcast on NBC.What you get:For $5 a month, Peacock Premium will give you streaming access to NBC's Sunday Night Football games, as well as Super Bowl LVI, the Thanksgiving game between the Buffalo Bills and New Orleans Saints, and the 2021 kick-off game between the Dallas Cowboys and Tampa Bay Buccaneers.The NFL's flex scheduling gives NBC the option to change the Sunday Night Football game of the week, which typically guarantees that the primetime game will be one of the week's best matchups.Premium (Monthly Plan) (small) Amazon Prime Video Amazon Though yon won't get local channels, NFL Network, or in-depth analysis, Amazon Prime Video members can watch select Thursday Night Football games with their subscription for no additional cost. A standalone Amazon Prime Video membership costs $9 a month, and the service is included as part of an Amazon Prime subscription for $119 per year or $13 a month.What you get:Amazon Prime Video will stream 11 Thursday Night Football games starting week five of the season. These game will also be broadcast on NFL Network and Fox. Since Amazon won't be streaming any additional games, Prime Video on its own is really only suitable for casual football fans who just want to stream a few games this season. Prime Video Monthly Subscription (small)Prime Monthly Subscription (small) Yahoo Sports app and NFL app Yahoo If you're only interested in watching in-market games without cable or an antenna, then you can stream live local and primetime games on a mobile device using the Yahoo Sports or NFL app. Both options are free and each app is available on iOS and Android smartphones and tablets. What you get:These apps provide live streaming for regular season local and primetime games, playoffs, and the Super Bowl. With that said, you can only watch the games on a mobile device. You'll also need to ensure that your location services are activated on your phone or tablet. Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 23rd, 2021

Macy"s (M) Braces for the Holiday Season, Unveils Hiring Plans

Macy's (M) will hire 76,000 full- and part-time employees across stores, call centers, distribution facilities and fulfillment centers. With the holiday season approaching, retailers are up and about with their hiring plans. The customary hiring practice for the festive season has swinged in early this year, thanks to tight labor market conditions. Macy's, Inc. M is the latest to join the list of retailers prepping for the additional staff support needed for the holiday season to meet consumers’ demand. The company unveiled plans to hire 76,000 full- and part-time job employees, offering competitive packages and bonuses. It is offering both temporary and permanent openings. Let’s take a closer look at the company’s hiring plans.Ramping Up Staff Strength for Holiday SeasonThe holiday season is traditionally characterized with high demand as consumers shop for gifting purposes as well as for themselves, making use of attractive deals and offers that retailers provide at this time of the year. The requirement for extra employee strength becomes crucial for several big-box retailers in order to manage high consumer traffic — across the digital and brick-and-mortar platforms — as well as to ensure smooth flow of merchandise and delivery services.This year, Macy's will be hiring nearly 76,000 full- and part-time employees across Bloomingdale’s, Bluemercury and Macy’s stores as well as its call centers, distribution facilities and fulfillment centers. The company stated that approximately 48,000 of these new job roles are for the holiday season, while the rest are permanent opportunities to join the company on a part- or full-time basis for the holidays and beyond.Macy's national hiring event will be held on Sep 23, 2021, across more than 500 stores. The hiring process will be carried out both online as well as via walk-ins. The hiring event is an opportunity for the company’s colleagues to earn a referral bonus of up to $500 for every friend or family member they recruit to join Macy’s. They also have an opportunity to earn additional income through various programs, such as the weekend bonus program and Path to Growth Incentive.The company will hire 21,200 employees for its fulfillment centers, including warehouse colleagues and forklift drivers. These workers are expected to play an important role in fulfilling demand online as well as the mobile app through tasks like receiving, sorting, picking, packing and shipping. The company will employ 50,000 Macy’s, 4,100 Bloomingdale and 315 Bluemercury staff for a variety of store roles. They will play a critical role in providing a satisfactory shopping experience. A majority of these roles are for the sales and experience team along with the merchandising and operations units. The opportunities range from entry-level to executive roles for candidates with a variety of skills and interests.Apart from these, the company will hire 300 employees for the Macy’s Credit and Customer Service (MCCS) to boost digital and in-store shopping experience as well as manage relationships with omnichannel and credit cardholder customers. It is also providing more than 200 technology-based jobs in its Johns Creek campus in the suburbs of Atlanta as the company expands its focus on improving omnichannel shopping experience and evolving its technology platforms as part of the Polaris strategyMacy’s hiring plans indicate that the company is focusing on boosting operations across the digital and physical facets, and thereby provide superior omnichannel experience to customers. The company is known for offering competitive pay and other benefits, a bilingual work environment as well as access to flexible schedules that allows employees to choose regular and optional overtime shifts.Image Source: Zacks Investment ResearchHiring Plans of Other Retailers This Holiday SeasonIn preparedness for the upcoming holiday sales, supermarket biggie — Walmart Inc. WMT — announced plans to appoint 20,000 new workers at more than 250 distribution centers, fulfillment centers and transportation offices. These job roles will be permanent and will be offered in part-time and full-time options. Kohl's Corporation KSS intends to recruit nearly 90,000 seasonal workers for several roles at its stores, distribution centers and e-commerce fulfilment centers.Ollies Bargain Outlet Holdings, Inc. OLLI announced plans to recruit more than 3,000 associates for full-time, part-time, seasonal and leadership positions across its 400 plus retail locations as well as three distribution centers. Other retailers who have unveiled hiring plans for this holiday season are DICK’S Sporting Goods and FLOWERS.COM and few others.As the holiday season accounts for a significant chunk of revenues, retailers are resorting to every effort to make the most of it, starting with prudent hiring plans. All said, we expect that Macy’s hiring efforts are likely to keep it well prepared for the upcoming seasonal rush and offer seamless shopping experience to customers.Shares of this Zacks Rank #1 (Strong Buy) company have gained 15% in the past three months compared with the industry’s rise of 3.7%.You can see the complete list of today’s Zacks #1 Rank stocks here. Infrastructure Stock Boom to Sweep America A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made. The only question is “Will you get into the right stocks early when their growth potential is greatest?” Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.Download FREE: How to Profit from Trillions on Spending for Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Macys, Inc. (M): Free Stock Analysis Report Kohls Corporation (KSS): Free Stock Analysis Report Walmart Inc. (WMT): Free Stock Analysis Report Ollies Bargain Outlet Holdings, Inc. (OLLI): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 22nd, 2021

Biotech Stock Roundup: Regulatory Updates From BIIB, BMY, EXEL, Setback for VRCA

Regulatory and pipeline updates from pharma giants like Biogen (BIIB) and Bristol Myers (BMY) have been some of the key highlights in the biotech sector during the past week. It has been a busy week for the biotech sector with quite a few drug approvals. Regulatory and pipeline updates from bigwigs like Biogen BIIB and Bristol Myers BMY, among others, have also grabbed the spotlight.Recap of the Week’s Most Important Stories:Regulatory and Pipeline Updates From Biogen: Biogen announced that the FDA approved Byooviz, a biosimilar referencing ophthalmology drug Lucentis (ranibizumab) for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV). The biosimilar has been developed in collaboration with Samsung Bioepis Co., Ltd. Per the company, this is the first ophthalmology biosimilar approved in the United States.  It was approved in Europe in August.Earlier, the Committee for Medicinal Products for Human Use (“CHMP”) issued a positive opinion and recommended granting marketing authorization to Vumerity (diroximel fumarate) in the European Union for the treatment of adults with relapsing-remitting multiple sclerosis. A final decision on the same is expected in the coming months.Biogen also announced top-line results from its phase II CONVEY study on pipeline candidate vixotrigine (BIIB074). The candidate is a non-opioid investigational oral pain drug being evaluated for the treatment of small fiber neuropathy (SFN). The study was a phase II placebo-controlled, double-blind, enriched enrollment randomized withdrawal study that enrolled 265 patients to evaluate the efficacy and safety of vixotrigine in treating pain experienced by participants with confirmed SFN that is idiopathic or associated with diabetes mellitus.  After a 4-week open-label run-in period, 123 responders to vixotrigine were randomized to receive either 200 mg or 350 mg vixotrigine or placebo twice-daily for 12 weeks in the double-blind portion of the study. The 200 mg dose achieved the primary endpoint of a statistically significant reduction in the mean average daily pain score versus placebo during the treatment period. However, the 350 mg arm failed to meet the primary endpoint. Nonetheless, the 350 mg dosage did achieve a statistically significant increase in the Patient Global Impression of Change at week 12, which is a measure of patients’ overall improvement when compared to baseline.Incyte Wins FDA Nod for AD Treatment:  Incyte INCY announced that the FDA has approved the cream formulation of its selective JAK1/JAK2 inhibitor ruxolitinib for the treatment of mild to moderate atopic dermatitis (AD).  Ruxolitinib cream has been approved under the brand name Opzelura for the short-term and non-continuous chronic treatment of mild to moderate AD in non-immunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable.  The approval makes Opzelura, the first and only topical formulation of a JAK inhibitor, approved in the United States. The FDA approval was based on data from the TRuE-AD (Topical Ruxolitinib Evaluation in Atopic Dermatitis) clinical trial program, consisting of two randomized, double-blind, vehicle-controlled phase III studies (TRuE-AD1 and TRuE-AD 2).Incyte currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Updates From Bristol Myers:  Bristol Myers Squibb announced that the FDA has accepted its biologics license application (BLA) for the fixed-dose combination of LAG-3-blocking antibody relatlimab and immuno-oncology Opdivo, administered as a single infusion, for the treatment of adult and pediatric patients (12 years and older and weighing at least 40 kg) with unresectable or metastatic melanoma. The agency has granted Priority Review to the application and set a target action date of Mar 19, 2022.  The submitted BLA was based on the positive efficacy and safety results of phase II/III RELATIVITY-047 study.Earlier, the CHMP recommended approval of Opdivo in combination with fluoropyrimidine and platinum-containing chemotherapy for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma whose tumors express PD-L1 with a combined positive score (CPS) ≥ 5.Exelixis’ Cabometyx Label Expansion: Exelixis EXEL announced that the FDA approved Cabometyx (cabozantinib) for yet another indication. The drug is now approved in the United States for the treatment of adult and pediatric patients 12 years of age and older with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior vascular endothelial growth factor receptor (VEGFR)-targeted therapy. The patients are also radioactive iodine-refractory or ineligible. The FDA approval was based on positive results from the phase III study, COSMIC-311, which demonstrated significant improvement in progression-free survival with Cabometyx versus placebo.  The drug is already approved in the United States for advanced renal cell carcinoma and hepatocellular carcinoma.Setback for Verrica:  Verrica Pharmaceuticals VRCA suffered a setback with the FDA issuing a Complete Response Letter (CRL) to its new drug application (NDA) for the lead product candidate, VP-102.  The NDA is seeking approval of the candidate for the treatment of molluscum contagiosum (molluscum), a highly contagious viral skin disease.The CRL was issued as the regulatory body has identified deficiencies at a facility of a contract manufacturing organization (CMO) that are not specifically related to the manufacturing of VP-102 but instead raise general quality issues at the facility. Nevertheless, the agency did not identify any clinical, safety or product-specific Chemistry, Manufacturing, and Controls (CMC) deficiencies related to VP-102. Per the company, the CMO implemented corrective actions to address the agency’s concerns and it expects a satisfactory resolution of the facility's identified deficiencies from the FDA within the next 30 business days. Meanwhile, Verrica will engage with the FDA to demonstrate that its good manufacturing practices, controls, and processes ensure that any deficiencies at the CMO do not affect the efficacy, safety or quality of VP-102.Seagen Wins Drug Approval: Seagen Inc. SGEN and partner Genmab A/S announced that the FDA has granted accelerated approval to Tivdak (tisotumab vedotin-tftv) for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. The accelerated approval was based on tumor response and the durability of the response. Continued approval for the same may be contingent upon verification and description of clinical benefit in confirmatory trials. The BLA for Tivdak was submitted in February 2021 and accepted with priority review in April 2021. The submission was based on the results of the innovaTV 204 study.PerformanceMedical - Biomedical and Genetics Industry 5YR % Return  Medical - Biomedical and Genetics Industry 5YR % ReturnThe Nasdaq Biotechnology Index has gained 0.83% in the past five trading sessions. Among the biotech giants, Incyte has gained 5.29% during the period. Over the past six months, shares of Moderna have soared 198.1%. (See the last biotech stock roundup here: Biotech Stock Roundup: MRNA Submits Vaccine Data, BMRN Down on Clinical Hold & More).Image Source: Zacks Investment ResearchWhat's Next in Biotech?Stay tuned for more pipeline and regulatory updates.  Infrastructure Stock Boom to Sweep America A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made. The only question is “Will you get into the right stocks early when their growth potential is greatest?” Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.Download FREE: How to Profit from Trillions on Spending for Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Biogen Inc. (BIIB): Free Stock Analysis Report Bristol Myers Squibb Company (BMY): Free Stock Analysis Report Incyte Corporation (INCY): Free Stock Analysis Report Exelixis, Inc. (EXEL): Free Stock Analysis Report Seagen Inc. (SGEN): Free Stock Analysis Report Verrica Pharmaceuticals Inc. (VRCA): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 22nd, 2021

Halloween store looks for a treat after cruel COVID trick

Adelaide Polsinelli is looking to work her magic on the Halloween store at 808 Broadway. COVID has been the final nail in the coffin for Halloween Adventure in the East Village (pictured top), which has been the ghostly go-to for New Yorkers for two decades. With revelry cancelled, the local... The post Halloween store looks for a treat after cruel COVID trick appeared first on Real Estate Weekly. Adelaide Polsinelli is looking to work her magic on the Halloween store at 808 Broadway. COVID has been the final nail in the coffin for Halloween Adventure in the East Village (pictured top), which has been the ghostly go-to for New Yorkers for two decades. With revelry cancelled, the local haunt has lost an estimated $2 million in sales and announced earlier this year that 2021 would be its last Halloween at the store. The owners have tapped Polsinelli to sell their ground floor, block-through, retail condo that currently houses two floors jam-packed with costumes, props, masks and magic, confirming they will be spirited away when a new owner takes over. “The pandemic dealt a major setback to New York City and the shift in retail shopping patterns to e-commerce, added a double blow to an already struggling retail market,” said Polsinelli, who nevertheless, sees a silver lining in the upheaval. “We are finally seeing signs of a strong resurgence as more retailers commit to long-term positions,” she said. “This boost in activity is just what Manhattan needs to remind retailers and investors that we are in a once-in-a-cycle opportunity and, as we turn the corner on COVID, more businesses will be placing bets on real estate.” Polsinelli expects the retail condo at the base of 808 Broadway, also known as 104-110 Fourth Avenue, is likely to cast a spell on a market rising from the ashes of COVID. “It’s an exceptional opportunity,” she said of the unit. “With 80 ft. of frontage on Fourth Avenue and 40 ft. on Broadway, it’s ideal for multi-tenanted use as well as any combination of owner-user possibilities. The expansive size along with 16 ft. high ceilings, makes it suitable for not only retail, but also medical, educational and office uses.” Located at the crossroads of Greenwich Village and the East Village, the property has entrances on both Avenues. Situated midblock, on Broadway between 11th and 12th Streets, its’ close to Washington Square Park, Union Square Park, the Greenmarket and the Union Square transit hub. Right at the center of NYU’s campus, it’s also near Beth Israel Medical Center and the new tech hub at 1 Union Square. All in, the retail condo totals 25,000 s/f, of which, 18,000 s/f is legal retail selling space. 10,000 s/f is ground floor retail which is duplexed with an 8,000 s/f lower level. There is another 7,000 s/f of sub- basement space. The building was constructed in 1887 with Gothic Revival detail by James Renwick Jr., who also designed the adjacent Grace Church and iconic St. Patrick’s Cathedral. The present seven-story, block-through building was converted to apartments in 1981 and renamed The Renwick, in honor of its architect. Family owned and operated for over 65 years, New York Costume Halloween Adventure is the largest designer, manufacturer and distributor of Halloween costumes and accessories in the world. The company has two other locations in Pennsylvania. Busy Philipps as Sheba Goodman in the Halloween episode of The Unbreakable Kimmy Schmidt filmed inside the 25,000 s/f retail condo. Image via Netflix. As well as being a local landmark, the Broadway store is a star in its own right, appearing in movies Six Degrees of Separation and The Dummy and featuring as a backdrop in an episode of Unbreakable Kimmy Schmidt. In an episode of Friends, Joey pays a visit to the store during a search for a Christmas costume. Polsinelli has listed to condo at $15.95 million. The post Halloween store looks for a treat after cruel COVID trick appeared first on Real Estate Weekly......»»

Category: realestateSource: realestateweeklySep 22nd, 2021

Google To "Exercise Option" To Buy $2.1 Billion Manhattan Office Building

Google To "Exercise Option" To Buy $2.1 Billion Manhattan Office Building Google plans to purchase a Manhattan office building for $2.1 billion, the most expensive for any single US office building since the virus pandemic began, according to WSJ.  The deal for the St. John's Terminal building in the Hudson Square neighborhood of Manhattan comes as the tech giant already leases the building and plans to exercise the option to buy in the first quarter of 2022.  The plans add to Google's massive footprint in Manhattan. The company previously announced it would invest $250 million into the metro area to expand its headcount from 12,000 to 14,000 over the next few years. "Our decision to exercise our option to purchase St. John's Terminal further builds upon our existing plans to invest more than $250 million this year in our New York campus presence. It is also an important part of meeting our previously announced racial equity commitments, which include continuing to grow our workforce in diverse communities like New York," Google said in a blog post.  The site will be Google's most prominent office outside of California, coming in at 1.7 million square feet. The deal is a positive sign for commercial real estate in the metro area, beaten down during the virus pandemic. Still, most of the company's workforce remains remote and may not return to the office until January.  Google also seems unphased by the real estate turmoil in China, where the possible default of the country's largest property developer, Evergrande, could be imminent and ripple through property markets.  Tyler Durden Tue, 09/21/2021 - 19:05.....»»

Category: blogSource: zerohedgeSep 21st, 2021

Google is doubling down on returning to the office with a $2.1 billion deal for a building in NYC

While Google has embraced remote work, it's also made it clear that employees will be expected to return to the office in the future. A rendering of Google's new office building in New York City. Oxford Properties Google will buy a New York City office building for $2.1 billion, The Wall Street Journal reports. The space, which Google already leases, is part of its Google Hudson Square campus. Google has said it expects employees to return to the office beginning in January 2022. See more stories on Insider's business page. Google is doubling down on returning to the office. The tech giant plans to buy a New York City office building for $2.1 billion, the most money paid for an office building in the US since the onset of the pandemic, according to The Wall Street Journal's Konrad Putzier. It's also one of the most expensive sales of an office building in US history, the Journal reports. Google already leases the building, located at 550 Washington St. on Manhattan's West side. The company announced in December 2018 that it was embarking on a major expansion to its presence in New York: a 1.7-million-square-foot campus dubbed "Google Hudson Square." Google said at the time that it planned to spend $1 billion outfitting three leased properties within walking distance of one another, one of which was 550 Washington St.According to the Journal, Google has an option to buy the property and plans to do so in early 2022.A spokesperson for Google did not immediately respond to Insider's request for comment on the deal. Google already owns a significant amount of commercial real estate in New York, including the Chelsea Market building, a building across the street at 111 Eighth Ave., and the Milk Building, which is also in Chelsea. The company employs roughly 12,000 workers in New York City, the Journal reports. A pedestrian passes by 550 Washington Street in 2018. Drew Angerer/Getty Images The building, known as St. John's Terminal, is located across from Pier 40 on the Hudson River. The property is currently being redeveloped as a green office building, complete with open spaces and a rooftop terrace, Curbed New York reported in 2018.The design will also incorporate some of the structure's history, including railway tracks that still exist inside the complex, Curbed reported.According to the Journal, the building is still undergoing renovations and won't upon until midway through 2023. With the new office purchase, Google is committing to a future where at least some work takes place in-person. The company previously planned to bring its workforce back to the office next month, but delayed employees' return until January 2022 due to the surge of the Delta variant.While Google has embraced remote work - it was one of the first major tech companies to delay its office reopening until after the 2020-2021 school year - the company has also made it clear that employees will be expected to return at some point. (Employees who do return will need to be vaccinated.)Google CEO Sundar Pichai has touted the benefits of working in person and previously said that the company plans to embrace a hybrid model of working. "We firmly believe that in-person, being together, having that sense of community, is super important for whenever you have to solve hard problems, you have to create something new," Pichai said during a video interview for Time 100 last year. "So we don't see that changing, so we don't think the future is just 100% remote or something."Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 21st, 2021

The Big Law career guide for law school students and young lawyers looking to land a job at an elite firms

Here's what law students and aspiring lawyers should know about landing a job at one of the top US law firms. Even though summer associate interviews are taking place virtually, recruiters and hiring partners say there are ways to establish meaningful connections and impress interviewers. Getty Images Each year, law school students interview for coveted summer associate jobs at Big law firms. Hiring partners and recruiting chairs shared their tips for impressing interviewers. They also shared hot practice areas, including data privacy and healthcare. Visit Business Insider's homepage for more stories. 2020 was a rollercoaster year for law school students and graduates, but 2021 is getting back on track.At the start of the pandemic, on-campus interviews (OCI) for law firms' summer associate programs - the primary pipeline for new talent at firms - were pushed back to later in the academic year, with January 2021 as the peak time for virtual interviews.This year, firms are returning to their usual schedule of summer interviews, looking for fresh talent to help keep up with a record number of deals in the past year.Insider has spoken to hiring partners and recruiters across the industry to collect the best tips for landing summer job at a Big Law firm.Big Law summer associate recruiting:Recruiting chairs and hiring partners at some of the most prestigious Big Law firms, including Kirkland & Ellis and Latham & Watkins, shared what they're looking for in an ideal candidate, from strong communication skills to an ability to work as a team player. They also discussed what students should know about their firm to demonstrate genuine interest, and share their top tips on impressing interviewers in a virtual setting. Read more:Hiring partners share how young lawyers can get hired at Paul Weiss, one of the country's top law firmsHow to get hired at Silicon Valley heavyweight Cooley, according to the firm's head of recruitingHow to land a job at Gibson Dunn, according to two partners leading the Big Law firm's recruitment efforts7 dos and don'ts of virtual interviews for Big Law summer associate programs, according to hiring decision-makers at Skadden and Latham & Watkins and a top industry recruiterKirkland & Ellis recruiting chairs and industry insiders lay out how to get hired at the top-ranking law firmHow to prep for an interview at elite law firm Latham & Watkins, according to its hiring chairs and 2 top industry recruitersHow to stand out during Morgan Lewis's individually-tailored virtual interview process, according to the Big Law firm's recruiting managerHow to impress interviewers and land a job at elite global law firm Baker McKenzie, according to its recruitment director, hiring partner, and 2 industry recruitersHow to land a summer associate gig at global law firm White & Case this year, according to 2 hiring partners and top legal recruitersHot practice areas in law:While law students aren't expected to know what type of law they want to specialize in off the bat, a demonstrated interest in a particular area can help set them apart during interviews. Attorneys and recruiters shared advice on what practice areas are especially in demand, which can give students interested in those areas a leg up.Bankruptcy, data privacy, and healthcare are among those in highest demand, especially with the sea changes caused by the pandemic. Tech is another buzzy area with a ton of demand, according to a recruiter.Read more: 9 recession-proof legal practice areas set to boom, according to top lawyers and recruitersRecruiters and headhunters say these are the 8 hottest law firms to work at if you want to work in the booming tech industryBig Law firms are launching new groups dedicated to data privacy and biometrics. Here's why they're betting changes in regulations are creating a huge opportunity.Staying on top of your game:Amid uncertainty and setbacks, industry experts recommended the best ways to keep legal skills sharp, from engaging in pro bono work to reading up on various aspects of the ever-evolving legal field.Read more:23 books on everything from Ruth Bader Ginsburg's writing collection to a mindfulness guide for lawyers that industry insiders say rising attorneys should readTop law firms are delaying their first-year associate classes. Here are 3 ways law school graduates can stay on top of their game in the meantime.Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 21st, 2021

L3Harris (LHX) Widens Indiana"s Campus for DOD"s Satellite Need

L3Harris (LHX) extends its campus in Indiana to address growing demand of the Department of Defense for advanced satellites. L3Harris Technologies LHX expands the size of its campus and workforce in Fort Wayne, IN to meet rising demand of the Department of Defense for advanced, resilient satellites. The company’s expertise in electro-optical or infrared technology and a very fresh approach to the problem set helped it clinch the deal from the agency.The new classified facility widens the total size of the campus to 150,000 square feet increasing the space for the missile defense satellite programs. This facility supports engineering, integration, testing and program management.L3Harris Technologies will invest in new technology, which will help detect hypersonic missiles, strengthen the missile defense system and defend against threats. It will also track global weather patterns alongside boosting the American economy. Also, the company is expanding its Palm Bay site to increase the capacity of satellite production.Other Strategic EffortsIn August, L3Harris Technologies was awarded a Full Rate Production delivery order for its AN/PRC-165 Handheld-Video Data Link (HH-VDL) tactical radios by the U.S. Marine Corps that will enhance warfighters’ situational awareness and battlefield connectivity. Also, the U.S. Navy selected the company’s electro-optical/infra-red (EO/IR) airborne systems to support its P-8A Poseidon. Deliveries of the same will be completed by the end of 2022.In September, it announced plans to divest its L3 ESSCO business to Communications & Power Industries. The motive behind the deal is to intensify focus on its core businesses, eliminate redundancies, and improve operational efficiency and cost structure.Company’s BacklogL3Harris Technologies had secured some key new contracts in the second quarter, thereby maintaining its healthy win rate of about 70% with total awards until August being nearly worth $700 million. As evidence, its backlog increased 7% organically year over year to above $20 billion with notable award activity across all domains likely to boost its revenues. Its trend of winning prime-level awards across all domains represents multibillion-dollar growth opportunities for the company.As far as government support is concerned, the company believes that the current U.S. administration's fiscal 2022 budget request, indicating an approximately 30% spending proposal over fiscal 2021 levels, for the National Oceanic and Atmospheric Administration (NOAA) should be beneficial for it. This budget is projected to reinforce L3Harris Technologies’ position as a leader in the weather payload and ground systems, creating a growth opportunity of $3 billion over the next decade.With a three-year pipeline opportunity of nearly $20 billion in the Space, there's immense scope for the company’s growth, backed by its electronics and optics capabilities. Such solid growth opportunities may boost investors’ confidence in this stock.Zacks Rank & Price PerformanceShares of this presently Zacks Rank #3 (Hold) company have gained 25.2% in the past year against the industry’s fall of 4%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.One Year Price PerformanceImage Source: Zacks Investment ResearchStocks to ConsiderA few better-ranked players from the same sector are Embraer S.A. ERJ, Textron Inc. TXT and VirTra, Inc. VTSI, all carrying a Zacks Rank #2 (Buy) at present.Embraer S.A., Textron and VirTra have a long-term (three-five years) earnings growth rate of 17%, 28.3% and 40% each.Earnings of Embraer S.A., Textron and VirTra delivered a trailing four-quarter surprise of 31.3%, 37.4% and 172.9%, respectively, on average. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report EmbraerEmpresa Brasileira de Aeronautica (ERJ): Free Stock Analysis Report Textron Inc. (TXT): Free Stock Analysis Report VirTra, Inc. (VTSI): Free Stock Analysis Report L3Harris Technologies Inc (LHX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

GPX vs. APEI: Which School Stock Investors Should Keep Tabs on?

School industry prospects continue to be solid on upbeat demand in the remainder of 2021. Let's see if GP Strategies (GPX) or American Public Education (APEI) is a better school stock at the moment. The Zacks Schools industry comprising for-profit education companies is well poised for the rest of 2021 as it continues reaping benefits from the rise in virtual delivery of education. Many industry bellwethers like GP Strategies Corporation GPX, American Public Education, Inc. APEI, Laureate Education, Inc. LAUR and Adtalem Global Education Inc. ATGE undertook initiatives like various online education platforms, cost-cutting efforts, investment in non-degree programs that are specifically aimed at meeting the educational needs of working adults in targeted professions.However, the industry is witnessing soft enrollment, increased competition, higher expenses for various programs and shortage of skilled labor. The collective industry has declined 65.3% so far this year compared with the Zacks Consumer Discretionary sector’s 4% fall. The S&P 500 Index has gained 20.6% in the same time frame.Nonetheless, the above-mentioned education providers are confident about the industry’s growth for the remainder of 2021, backed by their prudent cost management and a continued focus on driving profitability along with strategic initiatives.Image Source: Zacks Investment ResearchBased on above-mentioned tailwinds, let’s check out whether GP Strategies or American Public is more appealing to investors. It is to be noted that both companies are almost neck to neck in terms of market cap and currently carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Determinants of the StocksGP Strategies with a market cap of $363.5 million is a leading workforce transformation partner. It offers workforce performance solutions to organizations like Automotive, Financial Services, Defense and Aerospace, and Technology including Global Fortune 500 and other commercial customers across other major industries. The company primarily banks on global expansion through strategic acquisitions and subsidiaries’ establishment. Also, a large range of digital platforms, technical expertise, innovative solutions to clients and intelligent cost containment is adding to the positives.Conversely, American Public with a market cap of $497.3 million is an online and campus-based postsecondary education provider. It primarily serves approximately 91,500 students through two subsidiary institutions, namely American Public University System, Inc. or APUS and Hondros College of Nursing or HCN. The company steadily benefits from a strong visibility at HCN, solid enrollment momentum and robust digital marketing campaigns. Also, initiatives like affordable tuition, online programs, strategic efforts aimed at improving student success and strong digital marketing campaigns are likely to benefit the company going forward.Strong Brand Presence & Customer SpectrumAlthough GP Strategies is a slightly smaller company than American Public in terms of market cap, it has a large spectrum of customers as it serves more than 750 organizations across the world. In contrast, American Public primarily serves the military and public service communities through APUS, and the nursing and healthcare communities via HCN.Both companies’ customer-centric approach, and focus on technology is encouraging.Prospects & Stock PerformanceThe Zacks Consensus Estimate for GP Strategies' 2021 earnings indicates 42.5% growth from the prior-year reported number. The same for American Public’s bottom line for the year is likely to decline 25.6% from the year-ago reported figure. GP Strategies has a VGM Score of A.Shares of GP Strategies have gained 74.1% in the year-to-date period against American Public’s 12.7% fall. Nonetheless, both stocks have outperformed the industry’s 65.3% decrease in the same period.Thus, GP Strategies is a clear winner in terms of earnings growth prospects and share price performance.A Look at the Stocks’ Profitability & ValuationReturn on Equity in the trailing 12 months for GP Strategies is 9.1% compared with American Public and the industry’s 5.2% and 6.5%, respectively. GP Strategies provides impressive returns to investors than American Public and the industry.The trailing 12-month price-to-earnings multiple for GP Strategies and American Public is 18.49 and 22.74, respectively, compared with the industry’s 9.1. American Public’s shares are a bit costlier than GP Strategies and the industry.Our TakeGP Strategies certainly has an edge over American Public in terms of stock performance, expected earnings growth for 2021, return and valuation. Nonetheless, both companies remain optimistic about the overall industry growth trends, given solid demand for online education and professional courses, offsetting expansion-related higher costs and expenses. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Public Education, Inc. (APEI): Free Stock Analysis Report GP Strategies Corporation (GPX): Free Stock Analysis Report Laureate Education Inc. (LAUR): Free Stock Analysis Report Adtalem Global Education Inc. (ATGE): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

Louisiana State University Begins Disenrolling Students Not Compliant With Vaccine Rules

Louisiana State University Begins Disenrolling Students Not Compliant With Vaccine Rules By Ben Zeisloft of Campus Reform Louisiana State University has begun unenrolling students who failed to comply with COVID-19 regulations. As Fox 23 reports, seventy-eight students were told that they had been “resigned” from the school and would be refunded 50 percent of their fees. Louisiana State media relations director Ernie Ballard confirmed on Twitter that the students are “being contacted that they are being unenrolled from the university.” “As a student, you were sent numerous notifications regarding the Entry Test Requirement and reminders to comply,” read an email sent to the students. “Should you want to re-enroll at the university, you must complete the Entry Test Verification Survey. You will then need to email the Office of Academic Affairs… stating your desire to be reinstated and added back to your courses.” The university’s website states that all students had to “meet entry protocols” before September 10 in order to remain enrolled. The protocols included providing a negative COVID-19 test result no more than five days prior to arrival on campus, proof of a COVID-19 vaccination, or proof of a positive COVID-19 test result no more than 90 days prior to arrival. On Wednesday, Louisiana State University announced that its president, William Tate, was invited by the Biden administration to discuss the school’s COVID-19 regulations. Executives from Disney, Microsoft, Children’s Hospital of Philadelphia, and other organizations were also present. “It is an honor to present our successful COVID mitigation strategies to President Biden and the COVID Response Team, and we are proud that our multi-tiered approach to protecting our students, faculty and staff has been recognized at such an incredibly high level,” said Tate in the release. “Our strategies have worked, with more than 81 percent of our student body currently vaccinated, a monthly testing protocol that monitors the presence of the virus on our campus, wastewater testing that allows us to intervene before an outbreak occurs, and a vaccine/testing mandate at Tiger Stadium to keep our fans safe, too.” Ernie Ballard, the media relations director for Louisiana State University told Campus Reform that 78 students received an email stating that they were disenrolled from the university and must meet entry protocols by September 17 to re-enroll.   Tyler Durden Mon, 09/20/2021 - 21:20.....»»

Category: blogSource: zerohedgeSep 21st, 2021

Saturday links: specific chemical effects

On Saturdays we catch up with the non-finance related items that we didn’t get to earlier in the week. You can check... AutosRivian is driving an economic boom in Bloomington-Normal, Illinois. (nytimes.com)The Lucid Motors Air Dream Edition Range can go 520 miles on a charge per the EPA. (protocol.com)Infotainment systems are becoming a dangerous distraction to drivers. (slate.com)American society is designed around driving. (vox.com)EnergyGlobal windfarm installations are set to surge in 2021. (theguardian.com)VCs are investing bigly in long-duration batteries. (wsj.com)What's the real price for carbon emissions? (vox.com)EnvironmentModelers are having a hard time keeping up with modern wildfires. (wsj.com)Younger generations are more concerned about climate change. (pewresearch.org)Summer nights are increasingly 'abnormally hot.' (nytimes.com)You've heard of white roofs? Now there's white streets. (reasonstobecheerful.world)Don’t confuse grasslands with grass. (vox.com)How nudges can be used to prompt sustainability. (ft.com)RanchingThe megadrought is forcing ranchers to cull their herds. (slate.com)Can farmers coexist with wolves? (modernfarmer.com)SalmonCalifornia's wild chinook population is in steep decline. (washingtonpost.com)The world needs a salmon that can survive at higher temperatures. (hakaimagazine.com)TechnologyBrian X. Chen, "If personal information is no longer the currency that people give for online content and services, something else must take its place." (nytimes.com)Complex passwords are better but you need an easy way to store them. (wsj.com)Nobody encrypts their e-mails because it is a hassle. (newscientist.com)Codex, built by OpenAI, can write code by itself. (nytimes.com)Health carePost-pandemic, doctors are overwhelmed with patient messages. (theverge.com)Why nurses are leaving health care. (theconversation.com)HealthStagnating life expectancy is a bad sign for American society. (theatlantic.com)Why 80% of autoimmune disease patients are women. (scientificamerican.com)Are fresh foods and vegetables 'medicine'? (politico.com)How noise affects our brains. (wsj.com)It's time to get a flu shot. (nytimes.com)RestaurantsIn no way is it getting easier to run an independent restaurant. (eater.com)Restaurant owners are split on keeping dining rooms open. (wsj.com)FoodMidwest farmers are having a hard timing hiring workers, so they look overseas. (modernfarmer.com)Kroger ($KR) is working more closely with Instacart to speed up deliveries. (wsj.com)Why the price gap between real and fake meat will close. (axios.com)DrinkEurope's wine growers faced a host of challenges this year. (fortune.com)Why it's still a challenge to get a craft beer in a MLB stadium. (theathletic.com)SportsThe Forest Green Rovers are 'the greenest soccer club in the world.' (reasonstobecheerful.world)College sports programs are doubling down revenues opportunities. (wsj.com)Diversity makes for better football teams. (klementoninvesting.substack.com)EntertainmentThe Delta variant has taken a toll on the number of Americans willing to attend a live show. (morningconsult.com)People still love Netflix ($NFLX) original shows. (thestreamable.com)CollegeThe gender gap in colleges and universities starts before anyone actually hits campus. (theatlantic.com)Many professors feel betrayed by their administrations during pandemic. (slate.com)SchoolSchools are being forced to adapt on the fly to the Delta variant. (wsj.com)Schools across the country are struggling to hire workers, especially bus drivers. (nytimes.com)Smartwatches are the new no-go in classrooms. (wsj.com)MBAThe 2021-22 Businessweek Best Business School rankings have Stanford at the top. (bloomberg.com)The most diverse B-schools. (bloomberg.com)Earlier on Abnormal ReturnsCoronavirus links: sick societies. (abnormalreturns.com)What you missed in our Friday linkfest. (abnormalreturns.com)Podcast links: living longer. (abnormalreturns.com)Are you a financial adviser looking for some out-of-the-box thinking? Then check out our weekly e-mail newsletter. (newsletter.abnormalreturns.com)Mixed mediaFive key insights from Oliver Burkeman's new book "Four Thousand Weeks: Time Management for Mortals." (nextbigideaclub.com)A Q&A with Brad Stulberg author of "The Practice of Groundedness: A Transformative Path." (gq.com).....»»

Category: blogSource: abnormalreturnsSep 21st, 2021

Here are the fall 2021 reopening plans for Philadelphia-area colleges and universities

Local schools will have some semblance of normalcy on campus, with in-person instruction returning in full force......»»

Category: topSource: bizjournalsMay 7th, 2021

2021 Most Admired CEO: Gary May with the University of California Davis

May, who is UC Davis' first Black chancellor, is spearheading Aggie Square, a proposed $1.1 billion tech campus near UC Davis Medical Center......»»

Category: topSource: bizjournalsApr 9th, 2021

C-Suite Awards 2021: Opal Jones helps DOORWAYS kick off construction for a new campus amid pandemic

Opal Jones, president of the non.....»»

Category: topSource: bizjournalsFeb 18th, 2021

Medure Brothers bringing restaurant concept to Mayo campus

Brothers Matthew and David Medure will be opening a new concept on their campus in Spring 2021. The as-yet unnamed concept will seat around 200 guests and occupy a 7,000-square-foot space on the campus, with construction slated to begin this summ.....»»

Category: topSource: bizjournalsFeb 28th, 2020

Mandel to develop apartments at Sisters of Notre Dame Elm Grove campus

Milwaukee developer Mandel Group Inc. was selected to buy and develop new apartments on the School Sisters of Notre Dame’s 30-acre Elm Grove campus. The School Sisters plan to leave the Watertown Plank Road property in November 2021 and move into a .....»»

Category: topSource: bizjournalsFeb 24th, 2020

"Damn You To Hell, You Will Not Destroy America" - Here Is The "Spartacus COVID Letter" That"s Gone Viral

"Damn You To Hell, You Will Not Destroy America" - Here Is The 'Spartacus COVID Letter' That's Gone Viral Via The Automatic Earth blog, This is an anonymously posted document by someone who calls themselves Spartacus. Because it’s anonymous, I can’t contact them to ask for permission to publish. So I hesitated for a while, but it’s simply the best document I’ve seen on Covid, vaccines, etc. Whoever Spartacus is, they have a very elaborate knowledge in “the field”. If you want to know a lot more about the no. 1 issue in the world today, read it. And don’t worry if you don’t understand every single word, neither do I. But I learned a lot. The original PDF doc is here: Covid19 – The Spartacus Letter Hello, My name is Spartacus, and I’ve had enough. We have been forced to watch America and the Free World spin into inexorable decline due to a biowarfare attack. We, along with countless others, have been victimized and gaslit by propaganda and psychological warfare operations being conducted by an unelected, unaccountable Elite against the American people and our allies. Our mental and physical health have suffered immensely over the course of the past year and a half. We have felt the sting of isolation, lockdown, masking, quarantines, and other completely nonsensical acts of healthcare theater that have done absolutely nothing to protect the health or wellbeing of the public from the ongoing COVID-19 pandemic. Now, we are watching the medical establishment inject literal poison into millions of our fellow Americans without so much as a fight. We have been told that we will be fired and denied our livelihoods if we refuse to vaccinate. This was the last straw. We have spent thousands of hours analyzing leaked footage from Wuhan, scientific papers from primary sources, as well as the paper trails left by the medical establishment. What we have discovered would shock anyone to their core. First, we will summarize our findings, and then, we will explain them in detail. References will be placed at the end. Summary: COVID-19 is a blood and blood vessel disease. SARS-CoV-2 infects the lining of human blood vessels, causing them to leak into the lungs. Current treatment protocols (e.g. invasive ventilation) are actively harmful to patients, accelerating oxidative stress and causing severe VILI (ventilator-induced lung injuries). The continued use of ventilators in the absence of any proven medical benefit constitutes mass murder. Existing countermeasures are inadequate to slow the spread of what is an aerosolized and potentially wastewater-borne virus, and constitute a form of medical theater. Various non-vaccine interventions have been suppressed by both the media and the medical establishment in favor of vaccines and expensive patented drugs. The authorities have denied the usefulness of natural immunity against COVID-19, despite the fact that natural immunity confers protection against all of the virus’s proteins, and not just one. Vaccines will do more harm than good. The antigen that these vaccines are based on, SARS-CoV- 2 Spike, is a toxic protein. SARS-CoV-2 may have ADE, or antibody-dependent enhancement; current antibodies may not neutralize future strains, but instead help them infect immune cells. Also, vaccinating during a pandemic with a leaky vaccine removes the evolutionary pressure for a virus to become less lethal. There is a vast and appalling criminal conspiracy that directly links both Anthony Fauci and Moderna to the Wuhan Institute of Virology. COVID-19 vaccine researchers are directly linked to scientists involved in brain-computer interface (“neural lace”) tech, one of whom was indicted for taking grant money from China. Independent researchers have discovered mysterious nanoparticles inside the vaccines that are not supposed to be present. The entire pandemic is being used as an excuse for a vast political and economic transformation of Western society that will enrich the already rich and turn the rest of us into serfs and untouchables. COVID-19 Pathophysiology and Treatments: COVID-19 is not a viral pneumonia. It is a viral vascular endotheliitis and attacks the lining of blood vessels, particularly the small pulmonary alveolar capillaries, leading to endothelial cell activation and sloughing, coagulopathy, sepsis, pulmonary edema, and ARDS-like symptoms. This is a disease of the blood and blood vessels. The circulatory system. Any pneumonia that it causes is secondary to that. In severe cases, this leads to sepsis, blood clots, and multiple organ failure, including hypoxic and inflammatory damage to various vital organs, such as the brain, heart, liver, pancreas, kidneys, and intestines. Some of the most common laboratory findings in COVID-19 are elevated D-dimer, elevated prothrombin time, elevated C-reactive protein, neutrophilia, lymphopenia, hypocalcemia, and hyperferritinemia, essentially matching a profile of coagulopathy and immune system hyperactivation/immune cell exhaustion. COVID-19 can present as almost anything, due to the wide tropism of SARS-CoV-2 for various tissues in the body’s vital organs. While its most common initial presentation is respiratory illness and flu-like symptoms, it can present as brain inflammation, gastrointestinal disease, or even heart attack or pulmonary embolism. COVID-19 is more severe in those with specific comorbidities, such as obesity, diabetes, and hypertension. This is because these conditions involve endothelial dysfunction, which renders the circulatory system more susceptible to infection and injury by this particular virus. The vast majority of COVID-19 cases are mild and do not cause significant disease. In known cases, there is something known as the 80/20 rule, where 80% of cases are mild and 20% are severe or critical. However, this ratio is only correct for known cases, not all infections. The number of actual infections is much, much higher. Consequently, the mortality and morbidity rate is lower. However, COVID-19 spreads very quickly, meaning that there are a significant number of severely-ill and critically-ill patients appearing in a short time frame. In those who have critical COVID-19-induced sepsis, hypoxia, coagulopathy, and ARDS, the most common treatments are intubation, injected corticosteroids, and blood thinners. This is not the correct treatment for COVID-19. In severe hypoxia, cellular metabolic shifts cause ATP to break down into hypoxanthine, which, upon the reintroduction of oxygen, causes xanthine oxidase to produce tons of highly damaging radicals that attack tissue. This is called ischemia-reperfusion injury, and it’s why the majority of people who go on a ventilator are dying. In the mitochondria, succinate buildup due to sepsis does the same exact thing; when oxygen is reintroduced, it makes superoxide radicals. Make no mistake, intubation will kill people who have COVID-19. The end-stage of COVID-19 is severe lipid peroxidation, where fats in the body start to “rust” due to damage by oxidative stress. This drives autoimmunity. Oxidized lipids appear as foreign objects to the immune system, which recognizes and forms antibodies against OSEs, or oxidation-specific epitopes. Also, oxidized lipids feed directly into pattern recognition receptors, triggering even more inflammation and summoning even more cells of the innate immune system that release even more destructive enzymes. This is similar to the pathophysiology of Lupus. COVID-19’s pathology is dominated by extreme oxidative stress and neutrophil respiratory burst, to the point where hemoglobin becomes incapable of carrying oxygen due to heme iron being stripped out of heme by hypochlorous acid. No amount of supplemental oxygen can oxygenate blood that chemically refuses to bind O2. The breakdown of the pathology is as follows: SARS-CoV-2 Spike binds to ACE2. Angiotensin Converting Enzyme 2 is an enzyme that is part of the renin-angiotensin-aldosterone system, or RAAS. The RAAS is a hormone control system that moderates fluid volume in the body and in the bloodstream (i.e. osmolarity) by controlling salt retention and excretion. This protein, ACE2, is ubiquitous in every part of the body that interfaces with the circulatory system, particularly in vascular endothelial cells and pericytes, brain astrocytes, renal tubules and podocytes, pancreatic islet cells, bile duct and intestinal epithelial cells, and the seminiferous ducts of the testis, all of which SARS-CoV-2 can infect, not just the lungs. SARS-CoV-2 infects a cell as follows: SARS-CoV-2 Spike undergoes a conformational change where the S1 trimers flip up and extend, locking onto ACE2 bound to the surface of a cell. TMPRSS2, or transmembrane protease serine 2, comes along and cuts off the heads of the Spike, exposing the S2 stalk-shaped subunit inside. The remainder of the Spike undergoes a conformational change that causes it to unfold like an extension ladder, embedding itself in the cell membrane. Then, it folds back upon itself, pulling the viral membrane and the cell membrane together. The two membranes fuse, with the virus’s proteins migrating out onto the surface of the cell. The SARS-CoV-2 nucleocapsid enters the cell, disgorging its genetic material and beginning the viral replication process, hijacking the cell’s own structures to produce more virus. SARS-CoV-2 Spike proteins embedded in a cell can actually cause human cells to fuse together, forming syncytia/MGCs (multinuclear giant cells). They also have other pathogenic, harmful effects. SARS-CoV- 2’s viroporins, such as its Envelope protein, act as calcium ion channels, introducing calcium into infected cells. The virus suppresses the natural interferon response, resulting in delayed inflammation. SARS-CoV-2 N protein can also directly activate the NLRP3 inflammasome. Also, it suppresses the Nrf2 antioxidant pathway. The suppression of ACE2 by binding with Spike causes a buildup of bradykinin that would otherwise be broken down by ACE2. This constant calcium influx into the cells results in (or is accompanied by) noticeable hypocalcemia, or low blood calcium, especially in people with Vitamin D deficiencies and pre-existing endothelial dysfunction. Bradykinin upregulates cAMP, cGMP, COX, and Phospholipase C activity. This results in prostaglandin release and vastly increased intracellular calcium signaling, which promotes highly aggressive ROS release and ATP depletion. NADPH oxidase releases superoxide into the extracellular space. Superoxide radicals react with nitric oxide to form peroxynitrite. Peroxynitrite reacts with the tetrahydrobiopterin cofactor needed by endothelial nitric oxide synthase, destroying it and “uncoupling” the enzymes, causing nitric oxide synthase to synthesize more superoxide instead. This proceeds in a positive feedback loop until nitric oxide bioavailability in the circulatory system is depleted. Dissolved nitric oxide gas produced constantly by eNOS serves many important functions, but it is also antiviral against SARS-like coronaviruses, preventing the palmitoylation of the viral Spike protein and making it harder for it to bind to host receptors. The loss of NO allows the virus to begin replicating with impunity in the body. Those with endothelial dysfunction (i.e. hypertension, diabetes, obesity, old age, African-American race) have redox equilibrium issues to begin with, giving the virus an advantage. Due to the extreme cytokine release triggered by these processes, the body summons a great deal of neutrophils and monocyte-derived alveolar macrophages to the lungs. Cells of the innate immune system are the first-line defenders against pathogens. They work by engulfing invaders and trying to attack them with enzymes that produce powerful oxidants, like SOD and MPO. Superoxide dismutase takes superoxide and makes hydrogen peroxide, and myeloperoxidase takes hydrogen peroxide and chlorine ions and makes hypochlorous acid, which is many, many times more reactive than sodium hypochlorite bleach. Neutrophils have a nasty trick. They can also eject these enzymes into the extracellular space, where they will continuously spit out peroxide and bleach into the bloodstream. This is called neutrophil extracellular trap formation, or, when it becomes pathogenic and counterproductive, NETosis. In severe and critical COVID-19, there is actually rather severe NETosis. Hypochlorous acid building up in the bloodstream begins to bleach the iron out of heme and compete for O2 binding sites. Red blood cells lose the ability to transport oxygen, causing the sufferer to turn blue in the face. Unliganded iron, hydrogen peroxide, and superoxide in the bloodstream undergo the Haber- Weiss and Fenton reactions, producing extremely reactive hydroxyl radicals that violently strip electrons from surrounding fats and DNA, oxidizing them severely. This condition is not unknown to medical science. The actual name for all of this is acute sepsis. We know this is happening in COVID-19 because people who have died of the disease have noticeable ferroptosis signatures in their tissues, as well as various other oxidative stress markers such as nitrotyrosine, 4-HNE, and malondialdehyde. When you intubate someone with this condition, you are setting off a free radical bomb by supplying the cells with O2. It’s a catch-22, because we need oxygen to make Adenosine Triphosphate (that is, to live), but O2 is also the precursor of all these damaging radicals that lead to lipid peroxidation. The correct treatment for severe COVID-19 related sepsis is non-invasive ventilation, steroids, and antioxidant infusions. Most of the drugs repurposed for COVID-19 that show any benefit whatsoever in rescuing critically-ill COVID-19 patients are antioxidants. N-acetylcysteine, melatonin, fluvoxamine, budesonide, famotidine, cimetidine, and ranitidine are all antioxidants. Indomethacin prevents iron- driven oxidation of arachidonic acid to isoprostanes. There are powerful antioxidants such as apocynin that have not even been tested on COVID-19 patients yet which could defang neutrophils, prevent lipid peroxidation, restore endothelial health, and restore oxygenation to the tissues. Scientists who know anything about pulmonary neutrophilia, ARDS, and redox biology have known or surmised much of this since March 2020. In April 2020, Swiss scientists confirmed that COVID-19 was a vascular endotheliitis. By late 2020, experts had already concluded that COVID-19 causes a form of viral sepsis. They also know that sepsis can be effectively treated with antioxidants. None of this information is particularly new, and yet, for the most part, it has not been acted upon. Doctors continue to use damaging intubation techniques with high PEEP settings despite high lung compliance and poor oxygenation, killing an untold number of critically ill patients with medical malpractice. Because of the way they are constructed, Randomized Control Trials will never show any benefit for any antiviral against COVID-19. Not Remdesivir, not Kaletra, not HCQ, and not Ivermectin. The reason for this is simple; for the patients that they have recruited for these studies, such as Oxford’s ludicrous RECOVERY study, the intervention is too late to have any positive effect. The clinical course of COVID-19 is such that by the time most people seek medical attention for hypoxia, their viral load has already tapered off to almost nothing. If someone is about 10 days post-exposure and has already been symptomatic for five days, there is hardly any virus left in their bodies, only cellular damage and derangement that has initiated a hyperinflammatory response. It is from this group that the clinical trials for antivirals have recruited, pretty much exclusively. In these trials, they give antivirals to severely ill patients who have no virus in their bodies, only a delayed hyperinflammatory response, and then absurdly claim that antivirals have no utility in treating or preventing COVID-19. These clinical trials do not recruit people who are pre-symptomatic. They do not test pre-exposure or post-exposure prophylaxis. This is like using a defibrillator to shock only flatline, and then absurdly claiming that defibrillators have no medical utility whatsoever when the patients refuse to rise from the dead. The intervention is too late. These trials for antivirals show systematic, egregious selection bias. They are providing a treatment that is futile to the specific cohort they are enrolling. India went against the instructions of the WHO and mandated the prophylactic usage of Ivermectin. They have almost completely eradicated COVID-19. The Indian Bar Association of Mumbai has brought criminal charges against WHO Chief Scientist Dr. Soumya Swaminathan for recommending against the use of Ivermectin. Ivermectin is not “horse dewormer”. Yes, it is sold in veterinary paste form as a dewormer for animals. It has also been available in pill form for humans for decades, as an antiparasitic drug. The media have disingenuously claimed that because Ivermectin is an antiparasitic drug, it has no utility as an antivirus. This is incorrect. Ivermectin has utility as an antiviral. It blocks importin, preventing nuclear import, effectively inhibiting viral access to cell nuclei. Many drugs currently on the market have multiple modes of action. Ivermectin is one such drug. It is both antiparasitic and antiviral. In Bangladesh, Ivermectin costs $1.80 for an entire 5-day course. Remdesivir, which is toxic to the liver, costs $3,120 for a 5-day course of the drug. Billions of dollars of utterly useless Remdesivir were sold to our governments on the taxpayer’s dime, and it ended up being totally useless for treating hyperinflammatory COVID-19. The media has hardly even covered this at all. The opposition to the use of generic Ivermectin is not based in science. It is purely financially and politically-motivated. An effective non-vaccine intervention would jeopardize the rushed FDA approval of patented vaccines and medicines for which the pharmaceutical industry stands to rake in billions upon billions of dollars in sales on an ongoing basis. The majority of the public are scientifically illiterate and cannot grasp what any of this even means, thanks to a pathetic educational system that has miseducated them. You would be lucky to find 1 in 100 people who have even the faintest clue what any of this actually means. COVID-19 Transmission: COVID-19 is airborne. The WHO carried water for China by claiming that the virus was only droplet- borne. Our own CDC absurdly claimed that it was mostly transmitted by fomite-to-face contact, which, given its rapid spread from Wuhan to the rest of the world, would have been physically impossible. The ridiculous belief in fomite-to-face being a primary mode of transmission led to the use of surface disinfection protocols that wasted time, energy, productivity, and disinfectant. The 6-foot guidelines are absolutely useless. The minimum safe distance to protect oneself from an aerosolized virus is to be 15+ feet away from an infected person, no closer. Realistically, no public transit is safe. Surgical masks do not protect you from aerosols. The virus is too small and the filter media has too large of gaps to filter it out. They may catch respiratory droplets and keep the virus from being expelled by someone who is sick, but they do not filter a cloud of infectious aerosols if someone were to walk into said cloud. The minimum level of protection against this virus is quite literally a P100 respirator, a PAPR/CAPR, or a 40mm NATO CBRN respirator, ideally paired with a full-body tyvek or tychem suit, gloves, and booties, with all the holes and gaps taped. Live SARS-CoV-2 may potentially be detected in sewage outflows, and there may be oral-fecal transmission. During the SARS outbreak in 2003, in the Amoy Gardens incident, hundreds of people were infected by aerosolized fecal matter rising from floor drains in their apartments. COVID-19 Vaccine Dangers: The vaccines for COVID-19 are not sterilizing and do not prevent infection or transmission. They are “leaky” vaccines. This means they remove the evolutionary pressure on the virus to become less lethal. It also means that the vaccinated are perfect carriers. In other words, those who are vaccinated are a threat to the unvaccinated, not the other way around. All of the COVID-19 vaccines currently in use have undergone minimal testing, with highly accelerated clinical trials. Though they appear to limit severe illness, the long-term safety profile of these vaccines remains unknown. Some of these so-called “vaccines” utilize an untested new technology that has never been used in vaccines before. Traditional vaccines use weakened or killed virus to stimulate an immune response. The Moderna and Pfizer-BioNTech vaccines do not. They are purported to consist of an intramuscular shot containing a suspension of lipid nanoparticles filled with messenger RNA. The way they generate an immune response is by fusing with cells in a vaccine recipient’s shoulder, undergoing endocytosis, releasing their mRNA cargo into those cells, and then utilizing the ribosomes in those cells to synthesize modified SARS-CoV-2 Spike proteins in-situ. These modified Spike proteins then migrate to the surface of the cell, where they are anchored in place by a transmembrane domain. The adaptive immune system detects the non-human viral protein being expressed by these cells, and then forms antibodies against that protein. This is purported to confer protection against the virus, by training the adaptive immune system to recognize and produce antibodies against the Spike on the actual virus. The J&J and AstraZeneca vaccines do something similar, but use an adenovirus vector for genetic material delivery instead of a lipid nanoparticle. These vaccines were produced or validated with the aid of fetal cell lines HEK-293 and PER.C6, which people with certain religious convictions may object strongly to. SARS-CoV-2 Spike is a highly pathogenic protein on its own. It is impossible to overstate the danger presented by introducing this protein into the human body. It is claimed by vaccine manufacturers that the vaccine remains in cells in the shoulder, and that SARS- CoV-2 Spike produced and expressed by these cells from the vaccine’s genetic material is harmless and inert, thanks to the insertion of prolines in the Spike sequence to stabilize it in the prefusion conformation, preventing the Spike from becoming active and fusing with other cells. However, a pharmacokinetic study from Japan showed that the lipid nanoparticles and mRNA from the Pfizer vaccine did not stay in the shoulder, and in fact bioaccumulated in many different organs, including the reproductive organs and adrenal glands, meaning that modified Spike is being expressed quite literally all over the place. These lipid nanoparticles may trigger anaphylaxis in an unlucky few, but far more concerning is the unregulated expression of Spike in various somatic cell lines far from the injection site and the unknown consequences of that. Messenger RNA is normally consumed right after it is produced in the body, being translated into a protein by a ribosome. COVID-19 vaccine mRNA is produced outside the body, long before a ribosome translates it. In the meantime, it could accumulate damage if inadequately preserved. When a ribosome attempts to translate a damaged strand of mRNA, it can become stalled. When this happens, the ribosome becomes useless for translating proteins because it now has a piece of mRNA stuck in it, like a lace card in an old punch card reader. The whole thing has to be cleaned up and new ribosomes synthesized to replace it. In cells with low ribosome turnover, like nerve cells, this can lead to reduced protein synthesis, cytopathic effects, and neuropathies. Certain proteins, including SARS-CoV-2 Spike, have proteolytic cleavage sites that are basically like little dotted lines that say “cut here”, which attract a living organism’s own proteases (essentially, molecular scissors) to cut them. There is a possibility that S1 may be proteolytically cleaved from S2, causing active S1 to float away into the bloodstream while leaving the S2 “stalk” embedded in the membrane of the cell that expressed the protein. SARS-CoV-2 Spike has a Superantigenic region (SAg), which may promote extreme inflammation. Anti-Spike antibodies were found in one study to function as autoantibodies and attack the body’s own cells. Those who have been immunized with COVID-19 vaccines have developed blood clots, myocarditis, Guillain-Barre Syndrome, Bell’s Palsy, and multiple sclerosis flares, indicating that the vaccine promotes autoimmune reactions against healthy tissue. SARS-CoV-2 Spike does not only bind to ACE2. It was suspected to have regions that bind to basigin, integrins, neuropilin-1, and bacterial lipopolysaccharides as well. SARS-CoV-2 Spike, on its own, can potentially bind any of these things and act as a ligand for them, triggering unspecified and likely highly inflammatory cellular activity. SARS-CoV-2 Spike contains an unusual PRRA insert that forms a furin cleavage site. Furin is a ubiquitous human protease, making this an ideal property for the Spike to have, giving it a high degree of cell tropism. No wild-type SARS-like coronaviruses related to SARS-CoV-2 possess this feature, making it highly suspicious, and perhaps a sign of human tampering. SARS-CoV-2 Spike has a prion-like domain that enhances its infectiousness. The Spike S1 RBD may bind to heparin-binding proteins and promote amyloid aggregation. In humans, this could lead to Parkinson’s, Lewy Body Dementia, premature Alzheimer’s, or various other neurodegenerative diseases. This is very concerning because SARS-CoV-2 S1 is capable of injuring and penetrating the blood-brain barrier and entering the brain. It is also capable of increasing the permeability of the blood-brain barrier to other molecules. SARS-CoV-2, like other betacoronaviruses, may have Dengue-like ADE, or antibody-dependent enhancement of disease. For those who aren’t aware, some viruses, including betacoronaviruses, have a feature called ADE. There is also something called Original Antigenic Sin, which is the observation that the body prefers to produce antibodies based on previously-encountered strains of a virus over newly- encountered ones. In ADE, antibodies from a previous infection become non-neutralizing due to mutations in the virus’s proteins. These non-neutralizing antibodies then act as trojan horses, allowing live, active virus to be pulled into macrophages through their Fc receptor pathways, allowing the virus to infect immune cells that it would not have been able to infect before. This has been known to happen with Dengue Fever; when someone gets sick with Dengue, recovers, and then contracts a different strain, they can get very, very ill. If someone is vaccinated with mRNA based on the Spike from the initial Wuhan strain of SARS-CoV-2, and then they become infected with a future, mutated strain of the virus, they may become severely ill. In other words, it is possible for vaccines to sensitize someone to disease. There is a precedent for this in recent history. Sanofi’s Dengvaxia vaccine for Dengue failed because it caused immune sensitization in people whose immune systems were Dengue-naive. In mice immunized against SARS-CoV and challenged with the virus, a close relative of SARS-CoV-2, they developed immune sensitization, Th2 immunopathology, and eosinophil infiltration in their lungs. We have been told that SARS-CoV-2 mRNA vaccines cannot be integrated into the human genome, because messenger RNA cannot be turned back into DNA. This is false. There are elements in human cells called LINE-1 retrotransposons, which can indeed integrate mRNA into a human genome by endogenous reverse transcription. Because the mRNA used in the vaccines is stabilized, it hangs around in cells longer, increasing the chances for this to happen. If the gene for SARS-CoV-2 Spike is integrated into a portion of the genome that is not silent and actually expresses a protein, it is possible that people who take this vaccine may continuously express SARS-CoV-2 Spike from their somatic cells for the rest of their lives. By inoculating people with a vaccine that causes their bodies to produce Spike in-situ, they are being inoculated with a pathogenic protein. A toxin that may cause long-term inflammation, heart problems, and a raised risk of cancers. In the long-term, it may also potentially lead to premature neurodegenerative disease. Absolutely nobody should be compelled to take this vaccine under any circumstances, and in actual fact, the vaccination campaign must be stopped immediately. COVID-19 Criminal Conspiracy: The vaccine and the virus were made by the same people. In 2014, there was a moratorium on SARS gain-of-function research that lasted until 2017. This research was not halted. Instead, it was outsourced, with the federal grants being laundered through NGOs. Ralph Baric is a virologist and SARS expert at UNC Chapel Hill in North Carolina. This is who Anthony Fauci was referring to when he insisted, before Congress, that if any gain-of-function research was being conducted, it was being conducted in North Carolina. This was a lie. Anthony Fauci lied before Congress. A felony. Ralph Baric and Shi Zhengli are colleagues and have co-written papers together. Ralph Baric mentored Shi Zhengli in his gain-of-function manipulation techniques, particularly serial passage, which results in a virus that appears as if it originated naturally. In other words, deniable bioweapons. Serial passage in humanized hACE2 mice may have produced something like SARS-CoV-2. The funding for the gain-of-function research being conducted at the Wuhan Institute of Virology came from Peter Daszak. Peter Daszak runs an NGO called EcoHealth Alliance. EcoHealth Alliance received millions of dollars in grant money from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (that is, Anthony Fauci), the Defense Threat Reduction Agency (part of the US Department of Defense), and the United States Agency for International Development. NIH/NIAID contributed a few million dollars, and DTRA and USAID each contributed tens of millions of dollars towards this research. Altogether, it was over a hundred million dollars. EcoHealth Alliance subcontracted these grants to the Wuhan Institute of Virology, a lab in China with a very questionable safety record and poorly trained staff, so that they could conduct gain-of-function research, not in their fancy P4 lab, but in a level-2 lab where technicians wore nothing more sophisticated than perhaps a hairnet, latex gloves, and a surgical mask, instead of the bubble suits used when working with dangerous viruses. Chinese scientists in Wuhan reported being routinely bitten and urinated on by laboratory animals. Why anyone would outsource this dangerous and delicate work to the People’s Republic of China, a country infamous for industrial accidents and massive explosions that have claimed hundreds of lives, is completely beyond me, unless the aim was to start a pandemic on purpose. In November of 2019, three technicians at the Wuhan Institute of Virology developed symptoms consistent with a flu-like illness. Anthony Fauci, Peter Daszak, and Ralph Baric knew at once what had happened, because back channels exist between this laboratory and our scientists and officials. December 12th, 2019, Ralph Baric signed a Material Transfer Agreement (essentially, an NDA) to receive Coronavirus mRNA vaccine-related materials co-owned by Moderna and NIH. It wasn’t until a whole month later, on January 11th, 2020, that China allegedly sent us the sequence to what would become known as SARS-CoV-2. Moderna claims, rather absurdly, that they developed a working vaccine from this sequence in under 48 hours. Stephane Bancel, the current CEO of Moderna, was formerly the CEO of bioMerieux, a French multinational corporation specializing in medical diagnostic tech, founded by one Alain Merieux. Alain Merieux was one of the individuals who was instrumental in the construction of the Wuhan Institute of Virology’s P4 lab. The sequence given as the closest relative to SARS-CoV-2, RaTG13, is not a real virus. It is a forgery. It was made by entering a gene sequence by hand into a database, to create a cover story for the existence of SARS-CoV-2, which is very likely a gain-of-function chimera produced at the Wuhan Institute of Virology and was either leaked by accident or intentionally released. The animal reservoir of SARS-CoV-2 has never been found. This is not a conspiracy “theory”. It is an actual criminal conspiracy, in which people connected to the development of Moderna’s mRNA-1273 are directly connected to the Wuhan Institute of Virology and their gain-of-function research by very few degrees of separation, if any. The paper trail is well- established. The lab-leak theory has been suppressed because pulling that thread leads one to inevitably conclude that there is enough circumstantial evidence to link Moderna, the NIH, the WIV, and both the vaccine and the virus’s creation together. In a sane country, this would have immediately led to the world’s biggest RICO and mass murder case. Anthony Fauci, Peter Daszak, Ralph Baric, Shi Zhengli, and Stephane Bancel, and their accomplices, would have been indicted and prosecuted to the fullest extent of the law. Instead, billions of our tax dollars were awarded to the perpetrators. The FBI raided Allure Medical in Shelby Township north of Detroit for billing insurance for “fraudulent COVID-19 cures”. The treatment they were using? Intravenous Vitamin C. An antioxidant. Which, as described above, is an entirely valid treatment for COVID-19-induced sepsis, and indeed, is now part of the MATH+ protocol advanced by Dr. Paul E. Marik. The FDA banned ranitidine (Zantac) due to supposed NDMA (N-nitrosodimethylamine) contamination. Ranitidine is not only an H2 blocker used as antacid, but also has a powerful antioxidant effect, scavenging hydroxyl radicals. This gives it utility in treating COVID-19. The FDA also attempted to take N-acetylcysteine, a harmless amino acid supplement and antioxidant, off the shelves, compelling Amazon to remove it from their online storefront. This leaves us with a chilling question: did the FDA knowingly suppress antioxidants useful for treating COVID-19 sepsis as part of a criminal conspiracy against the American public? The establishment is cooperating with, and facilitating, the worst criminals in human history, and are actively suppressing non-vaccine treatments and therapies in order to compel us to inject these criminals’ products into our bodies. This is absolutely unacceptable. COVID-19 Vaccine Development and Links to Transhumanism: This section deals with some more speculative aspects of the pandemic and the medical and scientific establishment’s reaction to it, as well as the disturbing links between scientists involved in vaccine research and scientists whose work involved merging nanotechnology with living cells. On June 9th, 2020, Charles Lieber, a Harvard nanotechnology researcher with decades of experience, was indicted by the DOJ for fraud. Charles Lieber received millions of dollars in grant money from the US Department of Defense, specifically the military think tanks DARPA, AFOSR, and ONR, as well as NIH and MITRE. His specialty is the use of silicon nanowires in lieu of patch clamp electrodes to monitor and modulate intracellular activity, something he has been working on at Harvard for the past twenty years. He was claimed to have been working on silicon nanowire batteries in China, but none of his colleagues can recall him ever having worked on battery technology in his life; all of his research deals with bionanotechnology, or the blending of nanotech with living cells. The indictment was over his collaboration with the Wuhan University of Technology. He had double- dipped, against the terms of his DOD grants, and taken money from the PRC’s Thousand Talents plan, a program which the Chinese government uses to bribe Western scientists into sharing proprietary R&D information that can be exploited by the PLA for strategic advantage. Charles Lieber’s own papers describe the use of silicon nanowires for brain-computer interfaces, or “neural lace” technology. His papers describe how neurons can endocytose whole silicon nanowires or parts of them, monitoring and even modulating neuronal activity. Charles Lieber was a colleague of Robert Langer. Together, along with Daniel S. Kohane, they worked on a paper describing artificial tissue scaffolds that could be implanted in a human heart to monitor its activity remotely. Robert Langer, an MIT alumnus and expert in nanotech drug delivery, is one of the co-founders of Moderna. His net worth is now $5.1 billion USD thanks to Moderna’s mRNA-1273 vaccine sales. Both Charles Lieber and Robert Langer’s bibliographies describe, essentially, techniques for human enhancement, i.e. transhumanism. Klaus Schwab, the founder of the World Economic Forum and the architect behind the so-called “Great Reset”, has long spoken of the “blending of biology and machinery” in his books. Since these revelations, it has come to the attention of independent researchers that the COVID-19 vaccines may contain reduced graphene oxide nanoparticles. Japanese researchers have also found unexplained contaminants in COVID-19 vaccines. Graphene oxide is an anxiolytic. It has been shown to reduce the anxiety of laboratory mice when injected into their brains. Indeed, given SARS-CoV-2 Spike’s propensity to compromise the blood-brain barrier and increase its permeability, it is the perfect protein for preparing brain tissue for extravasation of nanoparticles from the bloodstream and into the brain. Graphene is also highly conductive and, in some circumstances, paramagnetic. In 2013, under the Obama administration, DARPA launched the BRAIN Initiative; BRAIN is an acronym for Brain Research Through Advancing Innovative Neurotechnologies®. This program involves the development of brain-computer interface technologies for the military, particularly non-invasive, injectable systems that cause minimal damage to brain tissue when removed. Supposedly, this technology would be used for healing wounded soldiers with traumatic brain injuries, the direct brain control of prosthetic limbs, and even new abilities such as controlling drones with one’s mind. Various methods have been proposed for achieving this, including optogenetics, magnetogenetics, ultrasound, implanted electrodes, and transcranial electromagnetic stimulation. In all instances, the goal is to obtain read or read-write capability over neurons, either by stimulating and probing them, or by rendering them especially sensitive to stimulation and probing. However, the notion of the widespread use of BCI technology, such as Elon Musk’s Neuralink device, raises many concerns over privacy and personal autonomy. Reading from neurons is problematic enough on its own. Wireless brain-computer interfaces may interact with current or future wireless GSM infrastructure, creating neurological data security concerns. A hacker or other malicious actor may compromise such networks to obtain people’s brain data, and then exploit it for nefarious purposes. However, a device capable of writing to human neurons, not just reading from them, presents another, even more serious set of ethical concerns. A BCI that is capable of altering the contents of one’s mind for innocuous purposes, such as projecting a heads-up display onto their brain’s visual center or sending audio into one’s auditory cortex, would also theoretically be capable of altering mood and personality, or perhaps even subjugating someone’s very will, rendering them utterly obedient to authority. This technology would be a tyrant’s wet dream. Imagine soldiers who would shoot their own countrymen without hesitation, or helpless serfs who are satisfied to live in literal dog kennels. BCIs could be used to unscrupulously alter perceptions of basic things such as emotions and values, changing people’s thresholds of satiety, happiness, anger, disgust, and so forth. This is not inconsequential. Someone’s entire regime of behaviors could be altered by a BCI, including such things as suppressing their appetite or desire for virtually anything on Maslow’s Hierarchy of Needs. Anything is possible when you have direct access to someone’s brain and its contents. Someone who is obese could be made to feel disgust at the sight of food. Someone who is involuntarily celibate could have their libido disabled so they don’t even desire sex to begin with. Someone who is racist could be forced to feel delight over cohabiting with people of other races. Someone who is violent could be forced to be meek and submissive. These things might sound good to you if you are a tyrant, but to normal people, the idea of personal autonomy being overridden to such a degree is appalling. For the wealthy, neural laces would be an unequaled boon, giving them the opportunity to enhance their intelligence with neuroprosthetics (i.e. an “exocortex”), and to deliver irresistible commands directly into the minds of their BCI-augmented servants, even physically or sexually abusive commands that they would normally refuse. If the vaccine is a method to surreptitiously introduce an injectable BCI into millions of people without their knowledge or consent, then what we are witnessing is the rise of a tyrannical regime unlike anything ever seen before on the face of this planet, one that fully intends to strip every man, woman, and child of our free will. Our flaws are what make us human. A utopia arrived at by removing people’s free will is not a utopia at all. It is a monomaniacal nightmare. Furthermore, the people who rule over us are Dark Triad types who cannot be trusted with such power. Imagine being beaten and sexually assaulted by a wealthy and powerful psychopath and being forced to smile and laugh over it because your neural lace gives you no choice but to obey your master. The Elites are forging ahead with this technology without giving people any room to question the social or ethical ramifications, or to establish regulatory frameworks that ensure that our personal agency and autonomy will not be overridden by these devices. They do this because they secretly dream of a future where they can treat you worse than an animal and you cannot even fight back. If this evil plan is allowed to continue, it will spell the end of humanity as we know it. Conclusions: The current pandemic was produced and perpetuated by the establishment, through the use of a virus engineered in a PLA-connected Chinese biowarfare laboratory, with the aid of American taxpayer dollars and French expertise. This research was conducted under the absolutely ridiculous euphemism of “gain-of-function” research, which is supposedly carried out in order to determine which viruses have the highest potential for zoonotic spillover and preemptively vaccinate or guard against them. Gain-of-function/gain-of-threat research, a.k.a. “Dual-Use Research of Concern”, or DURC, is bioweapon research by another, friendlier-sounding name, simply to avoid the taboo of calling it what it actually is. It has always been bioweapon research. The people who are conducting this research fully understand that they are taking wild pathogens that are not infectious in humans and making them more infectious, often taking grants from military think tanks encouraging them to do so. These virologists conducting this type of research are enemies of their fellow man, like pyromaniac firefighters. GOF research has never protected anyone from any pandemic. In fact, it has now started one, meaning its utility for preventing pandemics is actually negative. It should have been banned globally, and the lunatics performing it should have been put in straitjackets long ago. Either through a leak or an intentional release from the Wuhan Institute of Virology, a deadly SARS strain is now endemic across the globe, after the WHO and CDC and public officials first downplayed the risks, and then intentionally incited a panic and lockdowns that jeopardized people’s health and their livelihoods. This was then used by the utterly depraved and psychopathic aristocratic class who rule over us as an excuse to coerce people into accepting an injected poison which may be a depopulation agent, a mind control/pacification agent in the form of injectable “smart dust”, or both in one. They believe they can get away with this by weaponizing the social stigma of vaccine refusal. They are incorrect. Their motives are clear and obvious to anyone who has been paying attention. These megalomaniacs have raided the pension funds of the free world. Wall Street is insolvent and has had an ongoing liquidity crisis since the end of 2019. The aim now is to exert total, full-spectrum physical, mental, and financial control over humanity before we realize just how badly we’ve been extorted by these maniacs. The pandemic and its response served multiple purposes for the Elite: Concealing a depression brought on by the usurious plunder of our economies conducted by rentier-capitalists and absentee owners who produce absolutely nothing of any value to society whatsoever. Instead of us having a very predictable Occupy Wall Street Part II, the Elites and their stooges got to stand up on television and paint themselves as wise and all-powerful saviors instead of the marauding cabal of despicable land pirates that they are. Destroying small businesses and eroding the middle class. Transferring trillions of dollars of wealth from the American public and into the pockets of billionaires and special interests. Engaging in insider trading, buying stock in biotech companies and shorting brick-and-mortar businesses and travel companies, with the aim of collapsing face-to-face commerce and tourism and replacing it with e-commerce and servitization. Creating a casus belli for war with China, encouraging us to attack them, wasting American lives and treasure and driving us to the brink of nuclear armageddon. Establishing technological and biosecurity frameworks for population control and technocratic- socialist “smart cities” where everyone’s movements are despotically tracked, all in anticipation of widespread automation, joblessness, and food shortages, by using the false guise of a vaccine to compel cooperation. Any one of these things would constitute a vicious rape of Western society. Taken together, they beggar belief; they are a complete inversion of our most treasured values. What is the purpose of all of this? One can only speculate as to the perpetrators’ motives, however, we have some theories. The Elites are trying to pull up the ladder, erase upward mobility for large segments of the population, cull political opponents and other “undesirables”, and put the remainder of humanity on a tight leash, rationing our access to certain goods and services that they have deemed “high-impact”, such as automobile use, tourism, meat consumption, and so on. Naturally, they will continue to have their own luxuries, as part of a strict caste system akin to feudalism. Why are they doing this? Simple. The Elites are Neo-Malthusians and believe that we are overpopulated and that resource depletion will collapse civilization in a matter of a few short decades. They are not necessarily incorrect in this belief. We are overpopulated, and we are consuming too many resources. However, orchestrating such a gruesome and murderous power grab in response to a looming crisis demonstrates that they have nothing but the utmost contempt for their fellow man. To those who are participating in this disgusting farce without any understanding of what they are doing, we have one word for you. Stop. You are causing irreparable harm to your country and to your fellow citizens. To those who may be reading this warning and have full knowledge and understanding of what they are doing and how it will unjustly harm millions of innocent people, we have a few more words. Damn you to hell. You will not destroy America and the Free World, and you will not have your New World Order. We will make certain of that. *  *  * This PDF document contains 14 pages, followed by another 17 pages of references. For those, please visit the original PDF file at Covid19 – The Spartacus Letter. *  *  * We try to run the Automatic Earth on donations. Since ad revenue has collapsed, you are now not just a reader, but an integral part of the process that builds this site. Thank you for your support. Support the Automatic Earth in virustime. Donate with Paypal, Bitcoin and Patreon. Tyler Durden Mon, 09/27/2021 - 00:00.....»»

Category: dealsSource: nyt2 hr. 27 min. ago

"We Face Huge Pressure" - China"s Developer Cash Crunch Spreads To Sunac

"We Face Huge Pressure" - China's Developer Cash Crunch Spreads To Sunac By Sofia Horta e Costa, Bloomberg markets commentator and analyst, who follows up on our Friday article "The Housing Market Is Almost Frozen" - An Even Bigger Problem Emerges For China" in which we discussed the spread of Evergrande's contagion to Sunac Sunac has become the latest Chinese developer to run into liquidity issues, underscoring the challenging environment for the industry as the nation’s property slowdown deepens. The Hong Kong-listed real estate firm asked authorities in the city of Shaoxing for assistance after local housing curbs affected sales at one of the company’s projects, according to a letter from a subsidiary seen by Bloomberg. The market is almost frozen, the company said in the letter, addressing the local government. "We face huge pressure." Sunac’s plea for help shows the urgency of the cash crunch affecting the country’s indebted developers as the central government maintains rules to cut leverage in the industry and cool housing activity. China’s home prices are at risk of “meaningful downside” regardless of what happens to Evergrande, Citigroup analysts wrote in a recent note. Sunac’s dollar bonds slumped on Friday after the letter circulated among credit traders, with the 5.95% note due 2024 dropping to the lowest price on record. Sunac has the third-biggest weighting on a Bloomberg index of Chinese high yield dollar bonds, after Kaisa and a riskier note sold by ICBC this month. Sunac’s shares have slumped 50% this year, cutting the wealth of billionaire founder and chairman Sun Hongbin. He had a 44% shareholding in the company as of June, according to the data compiled by Bloomberg. The Tianjin-based business reported revenue of 230.6 billion yuan ($33 billion) in 2020. The property market fallout is hurting companies in a stronger financial position than Evergrande. Sunac, which has high speculative-grade ratings at the three global credit risk accessors, has about half the liabilities of its larger peer Evergrande. Sunac complies with two of China’s debt metrics known as the three red lines, and it’s looking to sell assets including its indoor ski parks business to raise cash. The Sunac group as a whole has “run into big hurdles and difficulties in terms of cash flow and liquidity,” it said in the letter. Tyler Durden Sun, 09/26/2021 - 23:00.....»»

Category: dealsSource: nyt3 hr. 27 min. ago

: Tony Awards bestow honors on ‘Moulin Rouge’ and ‘The Inheritance’ while heralding Broadway’s return from the pandemic

“Moulin Rouge! The Musical,” a splashy Broadway show based on the over-the-top Baz Luhrmann 2001 movie, proved the big winner of the 2021 Tony Awards, garnering the coveted prize of best musical......»»

Category: topSource: marketwatch3 hr. 27 min. ago